SOLVD Health Advances Development of Novel Test to Optimize GLP-1 Therapeutic Response

SAN DIEGO–(BUSINESS WIRE)–SOLVD Health, a patient intelligence company developing cutting-edge precision solutions to deliver better health outcomes, today announced the launch of two studies to validate its innovative GLP-1 patient stratification diagnostic platform. These studies aim to transform obesity and type 2 diabetes care by enabling healthcare providers to identify individuals most likely to benefit […]

Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced it has entered into an exclusive global collaboration and license agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Limited (02196.HK and 600106.SH), a leading innovation-driven global healthcare company, for the development, manufacturing and commercialization of YP05002, a small molecule glucagon-like peptide 1 (GLP-1) receptor […]

Wall Street Remains Cautious on Molson Coors Beverage Company (TAP)

Molson Coors Beverage Company (NYSE:TAP) is among the Top 15 Lowest P/E Ratios of the S&P 500 in 2025. On November 21, Piper Sandler lowered its price target for the stock to $50 from $52, while keeping a Neutral rating. The firm said it was revising its price target, taking into account recent developments in […]

Out-of-Pocket Pain From High-Deductible Plans Means Skimping on Care

David Garza sometimes feels as if he doesn’t have health insurance now that he pays so much to treat his Type 2 diabetes. His monthly premium payment of $435 for family coverage is roughly the same as the insurance at his previous job. But the policy at his current job carries an annual deductible of […]

What Does Wall Street Think About GoodRx Holdings (GDRX)?

GoodRx Holdings, Inc. (NASDAQ:GDRX) is one of the best affordable stocks under $5 to buy for the next 3 years. BofA slashed the price target on GoodRx Holdings, Inc. (NASDAQ:GDRX) to $3 from $3.40 on November 17 while maintaining an Underperform rating on the shares. The firm released the rating update after the company announced […]